Macroview Investment Management LLC Repligen Corp Transaction History

Macroview Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$165.87 - $220.95 $18,411 - $24,525	-111 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$180.37 - $226.26 $20,021 - $25,114	111 New	111 $22,000
Q4 2020 Jan 29, 2021	SELL	$148.08 - $206.57 $2,961 - $4,131	-20 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$122.51 - $158.27 $2,450 - $3,165	20 New	20 $3,000
Q4 2019 Feb 05, 2020	SELL	$73.84 - $93.08 $3,322 - $4,188	-45 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$76.65 - $95.51 $3,449 - $4,297	45 New	45 $3,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.